Nantahala Capital Management, LLC Syndax Pharmaceuticals Inc Transaction History

Nantahala Capital Management, LLC

  • $1.5 Billion
  • Q2 2024

A detailed history of Nantahala Capital Management, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 453,232 shares of SNDX stock, worth $8.6 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
453,232
Previous 453,232 -0.0%
Holding current value
$8.6 Million
Previous $9.3 Million -0.0%
% of portfolio
0.62%
Previous 0.62%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$18.82 - $23.79 $226,348 - $286,122
-12,027 Reduced 2.59%
453,232 $9.3 Million
Q1 2024

May 15, 2024
BUY
$19.71 - $24.57 $1.97 Million - $2.46 Million
100,000 Added 27.38%
465,259 $11.1 Million
Q4 2023

Feb 14, 2024
BUY
$11.39 - $21.67 $1.43 Million - $2.71 Million
125,228 Added 52.17%
365,259 $7.89 Million
Q3 2023

Nov 14, 2023
SELL
$14.52 - $21.77 $1.21 Million - $1.81 Million
-83,103 Reduced 25.72%
240,031 $3.49 Million
Q2 2023

Aug 14, 2023
SELL
$19.35 - $22.31 $12.6 Million - $14.6 Million
-652,571 Reduced 66.88%
323,134 $6.76 Million
Q4 2022

Feb 14, 2023
SELL
$20.64 - $26.24 $8.25 Million - $10.5 Million
-399,723 Reduced 29.06%
975,705 $24.8 Million
Q3 2022

Nov 10, 2022
SELL
$18.51 - $24.79 $23.8 Million - $31.9 Million
-1,287,659 Reduced 48.35%
1,375,428 $33.1 Million
Q2 2022

Aug 15, 2022
SELL
$13.64 - $19.48 $398,506 - $569,127
-29,216 Reduced 1.09%
2,663,087 $51.2 Million
Q1 2022

May 13, 2022
SELL
$14.84 - $22.15 $2.35 Million - $3.51 Million
-158,256 Reduced 5.55%
2,692,303 $46.8 Million
Q4 2021

Feb 14, 2022
BUY
$15.23 - $22.47 $2.95 Million - $4.35 Million
193,400 Added 7.28%
2,850,559 $62.4 Million
Q3 2021

Nov 15, 2021
BUY
$13.87 - $19.8 $885,211 - $1.26 Million
63,822 Added 2.46%
2,657,159 $50.8 Million
Q2 2021

Aug 16, 2021
BUY
$13.42 - $25.18 $7.93 Million - $14.9 Million
590,927 Added 29.51%
2,593,337 $44.5 Million
Q1 2021

May 14, 2021
BUY
$19.28 - $24.59 $3.93 Million - $5.02 Million
203,957 Added 11.34%
2,002,410 $44.8 Million
Q4 2020

Feb 16, 2021
BUY
$15.1 - $26.44 $6.94 Million - $12.2 Million
459,762 Added 34.34%
1,798,453 $40 Million
Q3 2020

Nov 16, 2020
BUY
$13.39 - $17.48 $17.9 Million - $23.4 Million
1,338,691 New
1,338,691 $19.8 Million

Others Institutions Holding SNDX

# of Institutions
201
Shares Held
87M
Call Options Held
268K
Put Options Held
76.8K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $1.07B
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email